Luxist Web Search

Search results

1. Results From The WOW.Com Content Network

2. SELLAS Life Sciences Group Third Quarter 2022 Earnings ... - AOL

   www.aol.com/news/sellas-life-sciences-group...

   SELLAS Life Sciences Group ( NASDAQ:SLS ) Third Quarter 2022 Results Key Financial Results Net loss: US$7.02m (flat on... SELLAS Life Sciences Group Third Quarter 2022 Earnings: US$0.34 loss per ...

3. Galena Biopharma - Wikipedia

   en.wikipedia.org/wiki/Galena_Biopharma

   Merger with Sellas Life Sciences. In 2017, Galena Biopharma Inc. announced a merger "with privately-held oncology company Sellas Life Sciences Group Ltd. in an all-stock transaction." The combined company was Sellas Life Science Group. The newly merged companies focused on the development of novel treatments for cancer.

4. SELLAS Life Sciences Group (NASDAQ:SLS) Will Have To ... - AOL

   www.aol.com/news/sellas-life-sciences-group...

   For premium support please call: 800-290-4726 more ways to reach us

5. Sellas' Ovarian Cancer Candidate Shows Clinical Benefit In ...

   www.aol.com/news/sellas-ovarian-cancer-candidate...

   SELLAS Life Sciences Group Inc (NASDAQ: SLS) announced topline data from its Phase 1/2 trial of galinpepimut-S (GPS) in WT1(+) relapsed or refractory platinum-resistant advanced metastatic ovarian ...

6. Calico (company) - Wikipedia

   en.wikipedia.org/wiki/Calico_(company)

   Calico, short for the California Life Company, [6] [7] was announced on September 18, 2013, prior to Google's restructuring and was co-founded by former Genentech chairman and CEO Arthur D. Levinson. [8] In Google's 2013 Founders Letter, Larry Page described Calico as a company focused on "health, well-being, and longevity ." [9]

7. Liminal BioSciences - Wikipedia

   en.wikipedia.org/wiki/Liminal_BioSciences

   Liminal BioSciences' aim to develop best or first-in-class therapies targeting indications with significant unmet needs, where a novel small molecule approach may be better suited using its drug discovery platform, specialized know-how and data-driven development plans. Liminal BioSciences is a development stage biopharmaceutical company ...

8. One Thing To Remember About The SELLAS Life Sciences ... - AOL

   www.aol.com/news/one-thing-remember-sellas-life...

   If you own shares in SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) then it's worth thinking about how it contributes... One Thing To Remember About The SELLAS Life Sciences Group, Inc. (NASDAQ:SLS ...

9. Verily - Wikipedia

   en.wikipedia.org/wiki/Verily

   Verily Life Sciences LLC, also known as Verily (formerly Google Life Sciences), is Alphabet Inc.'s research organization devoted to the study of life sciences. The organization was formerly a division of Google X, until August 10, 2015, when Sergey Brin announced that the organization would become an independent subsidiary of Alphabet Inc. with restructuring completed on October 2, 2015.